PSTX: Poseida Therapeutics Inc Company Profile & Statistics

About

Poseida Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focuses on developing therapeutics for high unmet medical needs. The company is developing a pipeline of solutions for the treatment of hematological malignancies and solid tumors, as well as vivo programs for liver-directed gene therapies for rare diseases. In addition, it offers CAR-T therapies for the treatment for cancer. Poseida Therapeutics Inc. is based in San Diego, California.

Info & Links

CEO

Kristin Yarema

Headquarters

9390 Towne Centre Drive, Suite 200
SAN DIEGO, CA 92121, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

330

Poseida Therapeutics Inc Statistics

Valuation Measures

Market Capitalization²

917.10M

Enterprise Value

926.67M

Enterprise Value/EBITDA(ttm)

-14.56

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

6.16

Price to Book(mrq)

10.59

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-40.28%

Profit Margin(ttm)

-70.06%

Return on Equity(ttm)

-72.26%

Return on Invested Capital(ttm)

-44.94%

Return on Assets(ttm)

-21.53%

Income Statement

Revenue(ttm)

150.86M

Revenue Per Share(ttm)

1.55

Gross Profit(ttm)

150.86M

EBITDA(ttm)³

-63.65M

Net Income Available to Common(ttm)

-60.76M

Diluted EPS(ttm)

-0.63

Share Statistics

Beta (5Y Monthly)

1.64

52-Week Change

229.02%

S&P 500 52-Week Change

25.97%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

97.47M

Dividend Yield

0.00%

Float⁴

94.94M

% Held by Insiders

2.90%

% Held by Institutions

46.87%

Balance Sheet

Total Cash(mrq)

230.85M

Total Cash Per Share(mrq)

2.37

Total Debt(mrq)

58.91M

Total Debt/Equity(mrq)

67.55%

Current Ratio(mrq)

3.20%

Quick Ratio(mrq)

3.20%

Book Value Per Share(mrq)

0.90

Cash Flow

Operating Cash Flow Per Share(ytd)

0.14

Free Cash Flow(ytd)

11.93M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

PSTX

Poseida Therapeutics Inc

Poseida Therapeutics Inc Profile